We have a team of editors dedicted to bringing you breaking news from within the medical sector. All our articles are completely unbiased and based on the industry as a whole. Please filter the news by your preferred profession below.
Apply to us in seconds, let us find you the perfect job.
Register as an Biomedical ScientistRefer a friend and earn £200 after they finish 4 weeks work!
Refer an Biomedical Scientist
Monday 21st September 2009
Hormone Replacement therapy (HRT) can raise the risk of dying from lung cancer, it has been claimed.
Research into the wider effects of HRT by biomedical scientists at the University of Nebraska Medical Centre on behalf of the Womens' Health Initiative - which were published in the Lancet - suggested that mortality rates were higher for those on the drugs.
This is despite there being no higher incidence of catching the condition to start with, the experts found.
Dr Apar Kishor Ganti from the University of Nebraska Medical Centre said this meant those women at a high risk of catching lung cancer should avoid HRT.
HRT is used to reproduce oestrogen and progesterone, the hormones associated with female reproduction.
These cease to be produced when the ovaries stop releasing eggs at the menopause.
The NHS website notes that conditions such as cancer of the womb lining are more likely when a woman does not take progesterone, as this substance protects this area.
Written by Mathew Horton
Locum Cytology Biomedical Scientist Locum Biomedical Scientist needed for a busy Cytology department. Thin Prep Logic Checking Primary...
Full infoWe are currently recruiting for experienced Biomedical Scientist for both locum and permanent vacancies across the Yorkshire...
Full infoMotivated and qualified Biomedical Scientist in Haematology required for an on-going job opportunity to work in London based...
Full infoCall 0845 230 6666
Fax 0845 230 6677
The Placement Group JustPhysio JustOT
Mediplacements is a member of The Placement Group.
Mediplacements partners with JustPhysio and JustOT